Picture of Mycelx Technologies logo

MYX Mycelx Technologies News Story

0.000.00%
gb flag iconLast trade - 00:00
IndustrialsHighly SpeculativeMicro CapSucker Stock

REG - MyCelx Tech. Corp. MyCelx Tech. Cp-MYXR - Director Dealings & Total Voting Rights

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240823:nRSW6160Ba&default-theme=true

RNS Number : 6160B  MyCelx Technologies Corporation  23 August 2024

23 August 2024

 

MYCELX Technologies Corporation

("MYCELX" or the "Company") (AIM:MYX)

 

Director Dealings & Total Voting Rights

 

MYCELX Technologies Corporation ("MYCELX" or the "Company"), the clean water
and clean air technology company established to transform the environmental
impact of industry, announces, further to the Placing and Subscription this
morning, the following participation by Directors of the Company.

 

 

 Director         Shares held prior to Admission  New Shares Purchased  Shares held post Admission  Percentage of Enlarged Issued Share Capital
 Thomas Lamb      325,175                         48,836                374,011                     1.54%
 Connie Mixon(1)  2,803,944                       100,632               2,931,576                   12.06%
 Andre Schnabl    118,011                         48,836                166,847                     0.69%

 

(1) Mrs. Mixon's shareholding includes 229,008 shares in the Company held by
her spouse.

 

 

Total Voting Rights

In conformity with the FCA's Disclosure Guidance and Transparency Rules (the
"Rules") provision 5.6.1, the Company would like to notify the market that
following Admission on 4 September 2024 its issued share capital will consist
of 24,315,271 Common Shares of US$0.025 each.

Shareholders should use 24,315,271 as the denominator for the calculations by
which they will determine if they are required to notify their interest in, or
a change to their interest in, the Company under the Rules.

Terms and definitions used in this announcement shall have the same meaning as
ascribed to them in the Proposed Placing and Subscription Announcement
released at 7:00 a.m. on 23 August 2024, unless the context requires
otherwise.

 

For further information please contact:

 

 MYCELX Technologies Corporation

 Connie Mixon, CEO                                              Tel: +1 888 306 6843

 Kim Slayton, CFO

 Canaccord Genuity Limited (Nominated Adviser and Sole Broker)

 Henry Fitzgerald-O'Connor                                      Tel: +44 20 7523 8000

 Charlie Hammond

 Celicourt Communications (Financial PR)

 Mark Antelme                                                   Tel: +44 20 7770 6424

 Jimmy Lea

 Charlie Denley-Myerson

 

Notifications of transactions of persons discharging managerial responsibility
or connected persons

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         1.   Thomas Lamb

                                                                   2.   Connie Mixon

                                                                   3.   Andre Schnabl
 2    Reason for the notification

 a)   Position/status                                              1.   Non-Executive Chairman

                                                                   2.   Chief Executive Officer

                                                                   3.   Non-Executive Director
 b)   Initial notification /Amendment                              Initial notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Mycelx Technologies Corporation

 b)   LEI                                                          213800UJZINIK2VD1G48

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Common shares of US$0.025

      Identification code                                          US62847T2024
 b)   Nature of the transaction                                    Purchase of Common Shares

 c)   Price(s) and volume(s)                                       Price(s)            Volume(s)

                                                                   1.   51.5 pence     1.   48,836

                                                                   2.   51.5 pence     2.   100,632

                                                                   3.   51.5 pence     3.   48,836

 d)   Aggregated information

      - Aggregated volume                                          N/A

      - Price                                                      N/A

 e)   Date of the transaction                                      23 August 2024

 f)   Place of the transaction                                     London Stock Exchange

d)

 

Aggregated information

- Aggregated volume

- Price

 

N/A

N/A

 

e)

 

Date of the transaction

 

23 August 2024

f)

 

Place of the transaction

London Stock Exchange

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHGZGZRGFZGDZM

Recent news on Mycelx Technologies

See all news